Ike Ogbaa
Vice President and Global Head of Medical Affairs at Immunovant
Ike Ogbaa, MD is currently the Vice President and Global Head of Medical Affairs at Immunovant. He is a seasoned professional with over 20 years of comprehensive experience in the clinical practice and pharmaceutical sectors. He most recently served in senior leadership positions as Vice President and Global Head of Medical Affairs at both Bluebird Bio and Chinook Therapeutics, a Novartis company. His extensive background includes progressively responsible roles in Medical Affairs at prominent Pharmaceutical companies such as Merck, Sanofi, GlaxoSmithKline, and Bayer, where he has successfully spearheaded drug launches across diverse therapeutic areas, including Nephrology, Endocrinology, Hematology, Neuroscience and Immunology.
Dr. Ogbaa earned a Bachelor’s degree in Psychology with a concentration in Behavioral Neuroscience from Yale University. He holds a Medical Doctorate from Rutgers Robert Wood Johnson Medical School in Piscataway, New Jersey, and completed his Internal Medicine residency at Baylor College of Medicine in Houston, Texas. Additionally, Dr. Ogbaa is certified in Medical Affairs and Medicines Development by King’s College London, and he has completed the AI in Pharma & Biotech certification from the MIT Sloan School of Management.
